Understanding Checkpoint Inhibitors
Checkpoint inhibitors play a crucial role in the field of cancer treatment. These inhibitors work by blocking proteins that bind to immune checkpoints in the body. Immune checkpoints are responsible for preventing the destruction of healthy cells by signaling T cells to stop attacking. However, this protective mechanism can hinder the immune system’s ability to destroy cancer cells.
By using checkpoint inhibitors, the proteins that bind to immune checkpoints are prevented from sending the signal to stop T cells from attacking. As a result, the inhibitors allow the immune system to unleash its full potential in attacking and destroying cancer cells.
Checkpoint inhibitors have shown remarkable effectiveness in the treatment of various types of cancers. They have been proven to be particularly effective against breast cancer, skin cancer, liver cancer, lung cancer, and Hodgkin lymphoma.
Advancements in CAR T Cell Therapy
One groundbreaking treatment option for certain types of lymphoma and leukemia is CAR T cell therapy. This innovative therapy involves the extraction of T cells from a patient’s body, followed by the introduction of a modified gene that enables these cells to identify and attack cancer cells. Once the genetic modification is complete, the enhanced T cells are reintroduced into the patient’s body.